Application of aluminum hydroxide for an in ovo live newcastle disease vaccine

Avian Diseases

Volumn 53, Issue 3, 2009, Pages 392-395

  Ohta, Hideyuki ^a   Ezoe, Shinsuke ^a   Yamazaki, Kenichi ^a   Kawai, Toru ^a   Honda, Takashi ^a  

^a Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

In ovo vaccine; Newcastle disease; Virus adsorbent material

Indexed keywords

ALUMINUM HYDROXIDE; IMMUNOLOGICAL ADJUVANT; VIRUS ANTIBODY; VIRUS VACCINE;

AGING; ANIMAL; ARTICLE; BLOOD; CHICK EMBRYO; CHICKEN; GERMFREE ANIMAL; IMMUNOLOGY; NEWCASTLE DISEASE;

ADJUVANTS, IMMUNOLOGIC; AGING; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; CHICKENS; NEWCASTLE DISEASE; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL VACCINES;

AVES; NEWCASTLE DISEASE VIRUS; SPONDIAS PURPUREA;

EID: 77649260144     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8555-120908-Reg.1     Document Type: Article

References (20)

1. Ahmad, J., and J. M. Sharma. Evaluation of a modified-live virus vaccine administered in ovo to protect chickens against Newcastle disease. Am. J. Vet. Res. 53:1999-2004. 1992.
2. Ahmad, J., and J. M. Sharma. Protection against hemorrhagic enteritis and Newcastle disease in turkeys by embryo vaccination with monovalent and bivalent vaccines. Avian Dis. 37:485-491. 1993.
3. Allan, W. H., and R. E. Gough. A standard haemagglutination inhibition test for Newcastle disease. 1. A comparison of macro and micro methods. Vet. Rec. 95:120-123. 1974.
4. Buxton, A., and G. Fraser. Animal microbiology, vol. 2. Blackwell Scientific Publ., London. p. 492. 1977.
5. Hem, S. L., and J. L. White. Characterization of aluminum hydroxide for use as an adjuvant in parenteral vaccines. J. Parenter. Sci. Technol. 38:2-10. 1984.
6. Karaca, K., J. M. Sharma, B. J. Winslow, D. E. Junker, S. Reddy, M. Cochran, and J. McMillen. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16:1496-1503. 1998.
7. Mast, J., C. Nanbru, M. Decaesstecker, B. Lambrecht, B. Couvreur, G. Meulemans, and T. van den Berg. Vaccination of chicken embryos with escape mutants of La Sota Newcastle disease virus induces a protective immune response. Vaccine 24:1756-1765. 2006.
8. Mebatsion, T., L. T. C. de Vaan, N. de Haas, A. Römer- Oberdörfer, and M. Braber. Identification of a mutation in editing of defective Newcastle disease virus recombinants that modulates P-gene mRNA editing and restores virus replication and pathogenicity in chicken embryos. J. Virol. 77:9259-9265. 2003.
9. Mebatsion, T., S. Verstegen, L. T. C. de Vaan, A. Römer- Oberdörfer, and C. C. Schrier. A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J. Virol. 75:420-428. 2001.
10. Nagai, Y., T. Yoshida, M. Hamaguchi, H. Naruse, M. Iinuma, K. Maeno, and T. Matsumoto. The pathogenicity of Newcastle disease virus isolated from migrating and domestic ducks and the susceptibility of the viral glycoproteins to proteolytic cleavage. Microbiol. Immunol. 24:173-177. 1980.
11. Park, M. S., J. Steel, A. García-Sastre, D. Swayne, and P. Palese. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U. S. A. 103:8203-8208. 2006.
12. Peleg, B. A., I. Samina, and J. Brenner. Immunization of chickens with live Newcastle disease vaccine adjuvanted with oil. Vaccine 11:1074-1076. 1993.
13. Perozo, F., P. Villegas, C. Estevez, I. R. Alvarado, L. B. Purvis, and E. Saume. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination. Avian Dis. 52:253-259. 2008.
14. Reddy, S. K., J. M. Sharma, J. Ahmad, D. N. Reddy, J. K. McMillen, S. M. Cook, M. A. Wild, and R. D. Schwartz. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 14:469-477. 1996.
15. Reed, L. J., and H. Muench. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497. 1938.
16. Ricks, C. A., A. Avakian, T. Bryan, R. Gildersleeve, E. Haddad, R. Ilich, S. King, L. Murray, P. Phelps, R. Poston, C. Whitfill, and C. Williams. In ovo vaccination technology. Adv. Vet. Med. 41:495-515. 1999.
17. Roy, P., A. T. Venugopalan, and A. Koteeswaran. Efficacy of live adjuvanted mesogenic Newcastle disease vaccine in chickens. Vaccine 17:2674-2676. 1999.
18. Sharma, J. M., and B. R. Burmester. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis. 26:134-149. 1982.
19. Steel, J., S. V. Burmakina, C. Thomas, E. Spackman, A. García-Sastre, D. E. Swayne, and P. Palese. A combination in ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 26:522-531. 2008.
20. Taylor, J., L. Christensen, R. Gettig, J. Goebel, J. F. Bouquet, T. R. Mickle, and E. Paoletti. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge. Avian Dis. 40:173-180. 1996.